Integrating the use of computational analysis techniques into modern pharmaceutical R&D

Authors

DOI:

https://doi.org/10.33448/rsd-v11i7.29672

Keywords:

Molecular docking simulation; Molecular dynamics simulation; Biological products; Drug discovery; Teaching.

Abstract

The path of the development process of new molecules for drugs is long and complex. Thus, in silico techniques are widely used for drug discovery. This paper aimed to analyze the importance of computational techniques in the current pharmaceutical research and development (R&D) scenario. This is an integrative literature review, which after the analysis of 202 articles found in scientific databases 11 were selected based on the inclusion criteria: research articles published in the last ten years, and exclusion criteria: theses, monographs, and review articles. The work shown here applied computational methods of drug development such as molecular docking, molecular dynamics and analyses of administration, distribution, metabolism, excretion and toxicity (ADMET). The phytoconstituents of the studies under analysis were isolated from the following plants Rhoeo spathacea, Pluchea indica, Piper Longum, Piper Nigrum, A. paniculata, E. harmandiana, S. flavescens, Justicia gendarussa, Burm f. and Punica granatum, besides the secondary metabolites such as flavonoids, flavones and polyphenols, which have been confirmed in these studies as drug candidates, by possessing potent inhibitory action against the proposed molecular targets. It was observed in these studies that computational drug development techniques, using the strategies of molecular docking and molecular dynamics, have been successful in discovering new chemical entities with potent biological activity from natural products. It denotes as prospects that R&D will increasingly play a leading role in simulation techniques, as these promote cost savings, reduced time, and medication innovation.

Author Biographies

Maria Rosana Marques da Silva, Centro Universitário Maurício de Nassau

Pharmacist Graduated from UNINASSAU- Parnaíba- Piauí

Polyanna dos Santos Negreiros, Centro Universitário Maurício de Nassau

Biomedical from the UNIVERSIDADE FEDERAL DO PIAUÍ (2014), Pharmacist from the ASSOCIACAO DE ENSINO SUPERIOR DO PIAUI-AESPI (2017), Master's in Pharmacology from the UNIVERSIDADE FEDERAL DO PIAUÍ (2018). Specialist in Clinical Cytology. He works mainly in the research of the pharmacological activity of medicinal plants and bioactive derivatives in the gastrointestinal tract. Composes the faculty of Uninassau College - Parnaíba

References

Almeida, V. L., Lopes, J. C. D., Oliveira, S. R., Donnici, & Montanari, C. A. (2010). Estudos de relações estrutura-atividade quantitativas (QSAR) de bis-benzamidinas com atividade antifúngica. Química Nova, 33(7), 1482-1489. https://doi.org/10.1590/S0100-40422010000700011.

Amaral, A. T., Andrade, C. H., Kümmerle, A. E., & Guido, R. V. C. (2017). A evolução da química medicinal no Brasil: avanços nos 40 anos da sociedade brasileira de química. Química Nova, 40(6), 694-700. https://doi.org/10.21577/0100-4042.20170075.

Andricopulo, A. D., Guido, R. V. C. & Oliva, G. (2010). Planejamento de fármacos, biotecnologia e química medicinal: aplicações em doenças infecciosas. Estudos Avançados, 24(70) 81-98. https://doi.org/10.1590/S0103-40142010000300006.

Asai, A., Koseki, J., Konno, M., Nishimura, T., Gotoh, N., Sato, T., Doki, Y., Mori, M., & Ishii, H. (2018). Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase. Heliyon, 4(12). https://doi.org/10.1016/j.heliyon.2018.e01021.

Barreiro, E. J. (2002). Estratégia de simplificação molecular no planejamento racional de fármacos: a descoberta de novo agente cardioativo. Química Nova, 25(6), 1172-1180. https://doi.org/10.1590/S0100-40422002000700018.

Barreiro, E. J. & Fraga, C. A. M. (2005). A questão da inovação em fármacos no Brasil: proposta de criação do programa nacional de fármacos (Pronfar). Química Nova, 28(15), 56-63. https://doi.org/10.1590/S0100-40422005000700012.

Bhowmik, D., Nandi, R., Prakash, A., & Kumar, D. (2021). Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis. Heliyon, 7(4). https://dx.doi.org/10.1016%2Fj.heliyon.2021.e06515.

Davella, R., Gurrapu, S., & Mamidala, E. (2021). Phenolic compounds as promising drug candidates against COVID-19 - an integrated molecular docking and dynamics simulation study. Materials Today: Proceedings,50(32). https://doi.org/10.1016/j.matpr.2021.05.595.

Gupta, P., Mohammad, T., Khan, P., Alajmi, M. F., Hussain, A., Rehman, M., T., & Hassan, M. I. (2019). Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy. Biomedicine & Pharmacotherapy, 118(81). https://doi.org/10.1016/j.biopha.2019.109245.

Jónsdóttir, S. Ó., Jorgensen, F. S., & Brunak, S. (2005). Métodos de previsão e bancos de dados dentro de quimioinformática: ênfase em drogas e candidatos a drogas. Bioinformática, 21(10), 2145-2160. https://doi.org/10.1093/bioinformatics/bti314.

Lakheira, S., Devlal, K., Ghosh, A., & Rana, M. (2021). In silico investigation of phytoconstituents of medicinal herb ‘Piper Longum’ against SARS-CoV-2 by molecular docking and molecular dynamics analysis. Results in Chemistry, 3(1). https://doi.org/10.1016/j.rechem.2021.100199.

Lin, X., Li, X., & Lin, X. (2020). A Review on Applications of Computational Methods in Drug Screening and Design. Molecules, 25(6). https://doi.org/10.3390/molecules25061375.

Lombardino, J., & Lowe, J. (2004). The role of the medicinal chemist in drug Discovery: then and now. Nat Rev Drug Discov, 3(1), p. 853-862. https://www.nature.com/articles/nrd1523.

Mendes, K. D. S., Silveira, R. C. C. P. & Galvão, C. M. (2008). Revisão integrativa: método de pesquisa para a incorporação de evidência na saúde e na enfermagem. Texto & Contexto Enfermagem, 17(4), 758-764. https://doi.org/10.1590/S0104-07072008000400018.

Nirmalraj, S., Gaythiri, E. Sivamurugan, M., Manivasagaperumal, R., Jayanthi, J., Prakash, P., & Selvam, K. (2021). Molecular docking based screening dynamics for plant based identified potential compounds of PDE12 inhibitors. Current Research in Green and Sustainable Chemistry, 7(3). https://doi.org/10.1016/j.crgsc.2021.100122.

Parasasty, V. D., Cindana, S., Ivan, F. X., Zahroh, H., & Sinaga, E. (2020). Structure-based discovery of novel inhibitors of Mycobacterium tuberculosis CYP121 from Indonesian natural products. Computational Biology and Chemistry, 85(32). https://doi.org/10.1016/j.compbiolchem.2020.107205.

Prieto-Martinez, F. D., Arciniega, M., & Medina-Franco, J. L. (2018). Molecular docking: current advances and challenges. TIP, 21(20). https://doi.org/10.22201/fesz.23958723e.2018.0.143.

Santi, M. D., Bouzidi, C., Gorod, N. S., Puiatti, M., Michel, S., Grougnet, R., & Ortega, M. G. (2019). In vitro biological evaluation and molecular docking studies of natural and semisynthetic flavones from Gardenia oudiepe (Rubiaceae) as tyrosinase inhibitors. Bioorganic Chemitry, 82, 241-245. https://doi.org/10.1016/j.bioorg.2018.10.034.

Sasidharan, S., & Saudagar, P. (2020). Flavones reversibly inhibit Leishmania donovani tyrosine aminotransferase by binding to the catalytic pocket: An integrated in silico-in vitro approach. International Journal of Biological Macromolecules, 164(77), 2987-3004. https://doi.org/10.1016/j.ijbiomac.2020.08.107.

Surucic, R., Travar, M., Petkovic, M. Tubic, B., Stojiljkovic, M., P., Grabez, M., Savikin, K., Zdunic, G., & Skrbic, R. (2021). Pomegranate peel extract polyphenols attenuate the SARS-CoV-2 S-glycoprotein binding ability to ACE2 Receptor: In silico and in vitro studies. Bioorganic Chemistry, 114(76). https://doi.org/10.1016/j.bioorg.2021.105145.

VERMA, D., Mitra, D., Paul, M., Chaudhary, P., Kamboj, A., Thatoi, H., Janmeda, P., Jain, D., Panneerselvam, P., Shrivastav, R., Pant, K., & Mohapatra, P. K. D. (2021). Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PLpro and Mpro/ 3CLpro: molecular docking and simulation studies of three pertinent medicinal plant natural componentes. Current Research in Pharmacology and Drug Discovery, 2(1). https://doi.org/10.1016/j.crphar.2021.100038.

Wei, B., Yang, W., Yan, Z. X., Zhang, Q., W., & Yan, R. (2018). Prenylflavonoids sanggenon C and kuwanon G from mulberry (Morus alba L.) as potent broad-spectrum bacterial β-glucuronidase inhibitors: Biological evaluation and molecular docking studies. Journal of Functional Foods, 65(48), 210-219. https://doi.org/10.1016/j.jff.2018.07.013.

Published

14/05/2022

How to Cite

SILVA, M. R. M. da .; NEGREIROS, P. dos S. .; SANTOS, P. S. dos . Integrating the use of computational analysis techniques into modern pharmaceutical R&D. Research, Society and Development, [S. l.], v. 11, n. 7, p. e3111729672, 2022. DOI: 10.33448/rsd-v11i7.29672. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/29672. Acesso em: 3 jul. 2022.

Issue

Section

Health Sciences